Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment

Dig Endosc. 2014 Jan;26(1):1-14. doi: 10.1111/den.12183. Epub 2013 Nov 12.

Abstract

Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment have been produced by the Japan Gastroenterological Endoscopy Society in collaboration with the Japan Circulation Society, the Japanese Society of Neurology, the Japan Stroke Society, the Japanese Society on Thrombosis and Hemostasis and the Japan Diabetes Society. Previous guidelines from the Japan Gastroenterological Endoscopy Society have focused primarily on prevention of hemorrhage after gastroenterological endoscopy as a result of continuation ofantithrombotic therapy, without considering the associated risk of thrombosis. The new edition of the guidelines includes discussions of gastroenterological hemorrhage associated with continuation of antithrombotic therapy, as well as thromboembolism associated with withdrawal of antithrombotic therapy.

Keywords: anticoagulant; antiplatelet agent; gastroenterological endoscopic examination and treatment; gastroenterological hemorrhage; thromboembolism.

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspirin / therapeutic use
  • Contraindications
  • Endoscopy, Gastrointestinal / adverse effects
  • Endoscopy, Gastrointestinal / standards*
  • Fibrinolytic Agents / therapeutic use
  • Gastrointestinal Hemorrhage / epidemiology
  • Gastrointestinal Hemorrhage / prevention & control
  • Humans
  • Japan
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Practice Guidelines as Topic
  • Program Development
  • Risk Factors
  • Societies, Medical

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Aspirin